177 related articles for article (PubMed ID: 31913865)
1. Population Pharmacokinetics of Vancomycin Under Continuous Renal Replacement Therapy Using a Polymethylmethacrylate Hemofilter.
Yamazaki S; Tatebe M; Fujiyoshi M; Hattori N; Suzuki T; Takatsuka H; Uchida M; Suzuki T; Ishii I
Ther Drug Monit; 2020 Jun; 42(3):452-459. PubMed ID: 31913865
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin pharmacokinetics in critically ill patients receiving continuous haemodiafiltration with a polyethyleneimine-coated polyacrylonitrile membrane.
Tsuruyama M; Yamashina T; Tsuruta M; Tsukada H; Fujimoto A; Nagano M; Kawamata Y; Takashima S; Hiraki Y
J Clin Pharm Ther; 2020 Oct; 45(5):1143-1148. PubMed ID: 32497268
[TBL] [Abstract][Full Text] [Related]
3. The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF).
Nakamura M; Oda S; Sadahiro T; Hirayama Y; Tateishi Y; Abe R; Hirasawa H
Transfus Apher Sci; 2009 Feb; 40(1):41-7. PubMed ID: 19109071
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetic Analysis of Meropenem in Critically Ill Patients With Acute Kidney Injury Treated With Continuous Hemodiafiltration.
Niibe Y; Suzuki T; Yamazaki S; Suzuki T; Takahashi N; Hattori N; Nakada TA; Oda S; Ishii I
Ther Drug Monit; 2020 Aug; 42(4):588-594. PubMed ID: 32049890
[TBL] [Abstract][Full Text] [Related]
5. Contribution of diafiltration and adsorption to vancomycin clearance in a continuous hemodiafiltration circuit model in vitro.
Uchida M; Sawada M; Yamazaki S; Suzuki T; Suzuki T; Ishii I
Artif Organs; 2022 Jun; 46(6):1086-1096. PubMed ID: 35048387
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter after polymyxin B-immobilized fiber column therapy of septic shock.
Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2008; 54(1):129-32. PubMed ID: 18204329
[TBL] [Abstract][Full Text] [Related]
8. Continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter for severe acute pancreatitis.
Abe R; Oda S; Shinozaki K; Hirasawa H
Contrib Nephrol; 2010; 166():54-63. PubMed ID: 20472992
[TBL] [Abstract][Full Text] [Related]
9. Treatment of septic shock with continuous HDF using 2 PMMA hemofilters for enhanced intensity.
Matsumura Y; Oda S; Sadahiro T; Nakamura M; Hirayama Y; Watanabe E; Abe R; Nakada TA; Tateishi Y; Oshima T; Shinozaki K; Hirasawa H
Int J Artif Organs; 2012 Jan; 35(1):3-14. PubMed ID: 22287204
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy between continuous hemodiafiltration with a PMMA high-performance membrane dialyzer and a PAN membrane hemofilter in the treatment of septic shock patients with acute renal failure.
Matsuda K; Moriguchi T; Harii N; Yanagisawa M; Harada D; Sugawara H
Contrib Nephrol; 2011; 173():182-190. PubMed ID: 21865791
[TBL] [Abstract][Full Text] [Related]
11. Effect of hemopurification rate on doripenem pharmacokinetics in critically ill patients receiving high-flow continuous hemodiafiltration.
Ohchi Y; Hidaka S; Goto K; Shitomi R; Nishida T; Abe T; Yamamoto S; Yasuda N; Hagiwara S; Noguchi T
Yakugaku Zasshi; 2011; 131(9):1395-9. PubMed ID: 21881315
[TBL] [Abstract][Full Text] [Related]
12. Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF).
Hidaka S; Goto K; Hagiwara S; Iwasaka H; Noguchi T
Yakugaku Zasshi; 2010 Jan; 130(1):87-94. PubMed ID: 20046071
[TBL] [Abstract][Full Text] [Related]
13. Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock.
Nakada TA; Oda S; Matsuda K; Sadahiro T; Nakamura M; Abe R; Hirasawa H
Mol Med; 2008; 14(5-6):257-63. PubMed ID: 18327291
[TBL] [Abstract][Full Text] [Related]
14. Comparison of efficacy between continuous hemodiafiltration with a PMMA membrane hemofilter and a PAN membrane hemofilter in the treatment of a patient with septic acute renal failure.
Matsuda K; Moriguchi T; Harii N; Goto J
Transfus Apher Sci; 2009 Feb; 40(1):49-53. PubMed ID: 19103511
[TBL] [Abstract][Full Text] [Related]
15. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.
Oda K; Jono H; Kamohara H; Nishi K; Tanoue N; Saito H
Pharm Res; 2020 May; 37(6):108. PubMed ID: 32468340
[TBL] [Abstract][Full Text] [Related]
16. Case report: therapeutic monitoring of vancomycin in an acute liver failure patient with anuria under high-flow continuous hemodiafiltration.
Ito Y; Nakade J; Seki A; Gabata R; Okazaki M; Nakanuma S; Fujita A; Shimada T; Yamashita T; Yagi S; Taniguchi T; Sai Y
J Pharm Health Care Sci; 2023 May; 9(1):15. PubMed ID: 37122008
[TBL] [Abstract][Full Text] [Related]
17. Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration.
Yamamoto T; Yasuno N; Katada S; Hisaka A; Hanafusa N; Noiri E; Yahagi N; Fujita T; Suzuki H
Antimicrob Agents Chemother; 2011 Dec; 55(12):5804-12. PubMed ID: 21911561
[TBL] [Abstract][Full Text] [Related]
18. In vitro analysis of factors affecting the continuous hemodiafiltration clearance of teicoplanin.
Sawada M; Uchida M; Yamazaki S; Suzuki T; Suzuki T; Ishii I
Artif Organs; 2023 Apr; 47(4):667-679. PubMed ID: 36310410
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
[TBL] [Abstract][Full Text] [Related]
20. Modulation of polymorphonuclear leukocyte apoptosis in the critically ill by removal of cytokines with continuous hemodiafiltration.
Hirano T; Hirasawa H; Oda S; Shiga H; Nakanishi K; Matsuda K; Nakamura M; Asai T; Kitamura N
Blood Purif; 2004; 22(2):188-97. PubMed ID: 15044817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
